wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34983601-52C27C95-7BC0-432F-9CB4-1ADC3FBA994B
Q34983601-52C27C95-7BC0-432F-9CB4-1ADC3FBA994B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-52C27C95-7BC0-432F-9CB4-1ADC3FBA994B
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.
P2860
Q34983601-52C27C95-7BC0-432F-9CB4-1ADC3FBA994B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34983601-52C27C95-7BC0-432F-9CB4-1ADC3FBA994B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbcdee6f16a60501b2995f5ccf84fa9448220acd
P2860
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.